Hot News : LyondellBasell Industries N.V. (NYSE:LYB), Aruba Networks, Inc. (NASDAQ:ARUN), ERBA Diagnostics, Inc. (NYSEMKT:ERB), Penn National Gaming Inc. (NASDAQ:PENN), UCP, Inc. (NYSE:UCP)

On Oct 24, LyondellBasell Industries N.V. (NYSE:LYB), said “tight” markets for its products may stall the narrower margins that it expects will ultimately come from lower oil prices. Third-quarter net income rose to $2.45 a share from $1.50 a year earlier. Profit excluding some items was $2.51, exceeding the $2.30 average of 18 analysts’ estimates compiled by Bloomberg. LyondellBasell Industries N.V. (NYSE:LYB) belongs to Basic Materials sector. Its net profit margin is 9.80% and weekly performance is -5.25%. On last trading day company shares ended up $87.19. LyondellBasell Industries N.V. (NYSE:LYB) distance from 50-day simple moving average (SMA50) is -17.93%.

Aruba Networks, Inc. (NASDAQ:ARUN) announced that it is expanding Aruba PartnerEdge Program to better address the needs of small to mid-sized enterprises (SME) and the channel partners that serve them. To support the effort, Aruba has adapted its internal organization. A devoted SME channel team, based in Aruba’s Portland, Oregon office, will focus on the SME channel. Aruba plans to expand the SME channel team globally before the end of calendar year 2014. Aruba Networks, Inc. (NASDAQ:ARUN) shares moved down -0.05% in last trading session and ended the day at $20.13. ARUN Gross Margin is 69.20% and its return on assets is -4.60%. Aruba Networks, Inc. (NASDAQ:ARUN) quarterly performance is 13.15%.

On Oct. 22, ERBA Diagnostics, Inc. (NYSEMKT:ERB) announced its fully integrated portfolio of in vitro diagnostics platforms and reagents for Hematology and Clinical Chemistry are now available to hospitals, references labs and physician clinics in Brazil. ERBA Diagnostics’ product line includes a comprehensive suite of instruments, reagents and kits for immunology, clinical chemistry, hematology, diabetes and infectious disease testing. On 27 October, ERBA Diagnostics, Inc. (NYSEMKT:ERB) shares moved down -4.48% and was closed at $2.77. ERB EPS growth in last 5 year was 0.00%. ERBA Diagnostics, Inc. (NYSEMKT:ERB) year to date (YTD) performance is 1.47%.

Imperial Capital dropped their price target on shares of Penn National Gaming (NASDAQ:PENN) from $20.00 to $17.00 in a research note issued on Friday. The firm currently has an “outperform” rating on the stock. Penn National Gaming Inc. (NASDAQ:PENN) ended the last trading day at $12.59. Company weekly volatility is calculated as 4.43% and price to cash ratio as 3.94. Penn National Gaming Inc. (NASDAQ:PENN) showed a weekly performance of 7.06%.

UCP, Inc. (NYSE:UCP) announced that it will release its financial results for the third quarter ending September 30, 2014 before the market opens on Monday, November 10, 2014. UCP, Inc. (NYSE:UCP) shares moved down -0.91% in last trading session and ended the day at $13.03. UCP Gross Margin is 19.70% and its return on assets is -1.50%. UCP, Inc. (NYSE:UCP) quarterly performance is 1.01%.